BLM administration induces IL-33 production in murine pulmonary macrophages, which recruits and activates immune cells and finally promotes pulmonary fibrosis (Cayrol and Girard, 2014; Li et al., 2014; Xia et al., 2015). The gene discussed is IL33; the disease is pulmonary fibrosis.